Identification of a new metabolite of macrolide immunosuppressant, like rapamycin and SDZ RAD, using high performance liquid chromatography and electrospray tandem mass spectrometry
K. Hallensleben et al., Identification of a new metabolite of macrolide immunosuppressant, like rapamycin and SDZ RAD, using high performance liquid chromatography and electrospray tandem mass spectrometry, J AM SOC M, 11(6), 2000, pp. 516-525
Citations number
19
Categorie Soggetti
Spectroscopy /Instrumentation/Analytical Sciences
Journal title
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY
Previously unknown metabolites from the two macrolide immunosuppressants ra
pamycin (sirolimus) and SDZ RAD [40-O-(2-hydroxyethyl)rapamycin] obtained a
fter in vitro incubation with human Liver microsomes have been purified. St
ructure elucidation was performed by nanoelectrospray ionization tandem mas
s spectrometry applying low energy collision activated dissociation. This i
onization method is, as shown here, a powerful tool to determine metabolic
pathways by analysis of even low abundance products. Product ion spectra of
the isolated metabolites indicate a new kind of biotransformation reaction
for rapamycin and SDZ RAD. The proposed metabolic pathway starts with an e
ster hydrolysis which leads to a ring-opened structure. A dehydration on C3
3-C34 and a supplementary hydrogenation at C33-C34 result in a structure si
milar to the ring-opened isomer with an single bond at C33-C34. (J Am Soc M
ass Spectrom 2000, 11, 516-525) (C) 2000 American Society for Mass Spectrom
etry.